You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 1, January 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Diagnosis
 •Prognosis/ Outcomes
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Genomic Typing of Uveal Melanoma—Reply

Tony Tsai, MD; Joan M. O’Brien, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We thank Damato and Coupland for their thoughtful comments on the issue of genetic prognostication for patients with uveal melanoma.

The benefits of any diagnostic test must be viewed in the context of the risks of its performance. We agree that genetic analysis is a powerful tool for providing prognostic information for patients with uveal melanoma. There is no reason to avoid tumor genotyping for the patient who understands the implications and limitations of the prognostic information and when no additional risk is required to obtain tissue for analysis, as is the case when enucleation or resection is the selected tumor treatment. However, much of the current controversy surrounds the use of fine-needle aspiration biopsy (FNAB) to add prognostic information when the diagnosis of uveal melanoma has been established noninvasively. Although FNAB has a long history of use for intraocular tumors . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Anterior Segment Optical Coherence Tomography as a Diagnostic Tool for Cyclodialysis Clefts
Aránzazu Mateo-Montoya and Sylvain Dreifuss
Arch Ophthalmol. 2009;127(1):109-110.
EXTRACT | FULL TEXT  

Role of Cytogenetics in Management of Uveal Melanoma
Jerry A. Shields, Carol L. Shields, Miguel Materin, Takami Sato, and Arupa Ganguly
Arch Ophthalmol. 2008;126(3):416-419.
EXTRACT | FULL TEXT  

RELATED LETTERS

Genomic Typing of Uveal Melanoma
Bertil Damato and Sarah E. Coupland
Arch Ophthalmol. 2009;127(1):113-114.
EXTRACT | FULL TEXT  

Genomic Typing of Uveal Melanoma—Reply
Jerry A. Shields, Carol L. Shields, Miguel Materin, Takami Sato, and Arupa Ganguly
Arch Ophthalmol. 2009;127(1):114.
EXTRACT | FULL TEXT  

Genomic Typing of Uveal Melanoma—Reply
Dennis M. Robertson
Arch Ophthalmol. 2009;127(1):114-115.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.